The group's principal activities are to design, manufacture and distribute food and drug administration and blood processing systems and their companion products that enable the manufacturer of cell therapy drugs from donor blood. These systems consist of an automated blood processing device and dedicated sterile single-use disposables that our customers use to manufacture cell therapy and products sourced from single units of blood. These products include hematopoietic stem cells from placental/cord blood for bone marrow rescue transplants and blood derived proteins and wound healing growth factors that provide surgeons with a means of arresting bleeding and/or bonding excised tissue together thereby initiating cellular repair of the excised tissues. The group primarily operates in the United States, with exports to Europe and Asia.
